Back |
home / stock / orpn / orpn message board
Subject | By | Source | When |
---|---|---|---|
$ORPN implements 1:5 reverse split effective on date | DewDiligence | investorshub | 09/18/2017 8:27:54 PM |
you are correct this play could rise very | jcbaby | investorshub | 08/24/2017 7:36:46 PM |
its a revised outlook lmaooooo | theprofit444 | investorshub | 08/24/2017 4:18:27 PM |
didn't you say 10 awhile back lol lets | jcbaby | investorshub | 08/23/2017 4:40:44 PM |
itll be 4 dollars a share by yr end | theprofit444 | investorshub | 08/23/2017 12:26:07 AM |
$ORPN 2Q17 PR: | DewDiligence | investorshub | 08/04/2017 8:45:03 PM |
this could rocket over a dollar in a | jcbaby | investorshub | 08/01/2017 4:14:27 PM |
Two months has elapsed since the post I'm | DewDiligence | investorshub | 07/28/2017 10:48:39 PM |
$ORPN buy 0.656 | stocktrademan | investorshub | 07/22/2017 5:48:54 PM |
should be an interesting day for this stock | jcbaby | investorshub | 07/03/2017 11:04:41 AM |
* * $ORPN Video Chart 06-30-17 * * | ClayTrader | investorshub | 06/30/2017 9:09:31 PM |
Indeed! On a day it made nearly 100% | Klinsmann | investorshub | 06/30/2017 4:46:27 PM |
Awfully quiet in here | jr525 | investorshub | 06/30/2017 3:45:20 PM |
$ORPN will be at 4 dollars a share | theprofit444 | investorshub | 06/26/2017 5:41:49 PM |
True! Very well settled above 0,40 | Klinsmann | investorshub | 06/26/2017 1:01:21 PM |
danrocks: ORPN Stock is number 97 for the largest percentage gain out of 250 stocks. $ORPN ORPN is u | danrocks | investorshangout | 12/21/2015 11:14:13 PM |
danrocks: ORPN Stock is number 168 for the largest percentage gain out of 250 stocks. $ORPN ORPN is | danrocks | investorshangout | 12/19/2015 4:13:00 AM |
clayton: ORPN 4.36 Bio Blast Pharma Ltd $ORPN stock added to my watch list. Right now with ORPN I am | clayton | investorshangout | 12/19/2015 3:01:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Bioblast Pharma Ltd. Company Name:
ORPN Stock Symbol:
NASDAQ Market:
Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...
CORAL GABLES, FL / ACCESSWIRE / February 19, 2019 / The success of healthcare stock market is based on whether or not companies in the healthcare industry have the ability to meet the growing demands of consumers. It's no longer a question of simply creating treatment options and offering ...
Diversifies Seelos’ pipeline in rare diseases Collaborates with Team Sanfilippo Foundation in development of Trehalose in Sanfilippo syndrome NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announc...